Oncolead
Pre-clinicalOncoLead offers cellular screens designed to accelerate the decision making process for the development of anticancer drugs. Its information driven cell panel screen is to help scientists from all sectors to discover and develop novel and innova- tive anticancer medicines faster.
Founded
2017
Focus
Diagnostics
About
OncoLead offers cellular screens designed to accelerate the decision making process for the development of anticancer drugs. Its information driven cell panel screen is to help scientists from all sectors to discover and develop novel and innova- tive anticancer medicines faster.
Funding History
1Total raised: $3.2M
Seed$3.2MHigh-Tech GründerfondsSep 15, 2020
Company Info
TypePrivate
Founded2017
LocationMunich, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile